๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intensive care of the patient with cirrhosis

โœ Scribed by Jody C. Olson; Julia A. Wendon; David J. Kramer; Vicente Arroyo; Rajiv Jalan; Guadalupe Garcia-Tsao; Patrick S. Kamath


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
549 KB
Volume
54
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Acute deterioration of patients with cirrhosis manifests as multiple organ failure requiring admission to an intensive care unit. Precipitating events may be viral hepatitis, typically in Asia, and drug or alcoholic hepatitis and variceal hemorrhage in the West. Patients with cirrhosis in the intensive care unit have a high mortality, and each admission is associated with a mean charge of US $116,200. Prognosis is determined by the number of organs failing (sequential organ failure assessment [SOFA] score), the presence of infection, and the degree of liver dysfunction (Child-Turcotte-Pugh or Model for End-Stage Liver Disease scores). The most common organ failing is the kidney; sepsis is associated with further deterioration in liver function by compromise of the microcirculation. Care of these critically ill patients with impending multiple organ failure requires a team approach with expertise in both hepatology and critical care. Treatment is aimed at preventing further deterioration in liver function, reversing precipitating factors, and supporting failing organs. Liver transplantation is required in selected patients to improve survival and quality of life. Treatment is futile in some patients, but it is difficult to identify these patients a priori. Artificial and bioartificial liver support systems have thus far not demonstrated significant survival benefit in these patients. (HEPATOLOGY 2011;54:1864-1872) Epidemiology: Patients with Cirrhosis Requiring Intensive Care A pproximately 26,000 patients with cirrhosis in the United States require intensive care each year, as identified by the need for mechanical ventilation and invasive cardiovascular monitoring. The in-hospital mortality in these patients is greater than 50%, and mean length of hospitalization is 13.8 days. The total annual charges associated with intensive care unit (ICU) admissions alone are US $3 billion, or mean charges of US $116,200 per admission (data not published). More concerning is the finding that ICU mortality rates associated with cirrhosis have remained essentially unchanged over 20 years. The optimal care of the patient with cirrhosis in the ICU is discussed in this review.


๐Ÿ“œ SIMILAR VOLUMES


Intensive care unit admissions with cirr
โœ J E Zimmerman; D P Wagner; M G Seneff; R B Becker; X Sun; W A Knaus ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 224 KB

Prognosis for acutely ill patients with cirrhosis is in-hepatic portosystemic shunting [3][4][5][6][7] and other operative fluenced by the severity of hepatic abnormalities and by procedures. [8][9][10][11] These systems have also been useful for dysfunction of other organ systems. The purpose of th